Amlodipine Besylate Patent Expiration
Amlodipine Besylate was first introduced by Viatris Specialty Llc
Amlodipine Besylate Patents
Given below is the list of patents protecting Amlodipine Besylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Norliqva | US11253474 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Norliqva | US11458095 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Norliqva | US11723866 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Norliqva | US12005141 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Norliqva | US12226528 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Amlodipine Besylate | US6828339 | Amlodipine salt forms and processes for preparing them |
Nov 20, 2022
(Expired) | Synthon Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Amlodipine Besylate's patents.
Latest Legal Activities on Amlodipine Besylate's Patents
Given below is the list recent legal activities going on the following patents of Amlodipine Besylate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical
| 07 Jan, 2013 | US6828339 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 16 Apr, 2007 | US6828339 |
| Correspondence Address Change Critical
| 16 Apr, 2007 | US6828339 |
| Correspondence Address Change Critical
| 09 Mar, 2005 | US6828339 |
| Recordation of Patent Grant Mailed Critical
| 07 Dec, 2004 | US6828339 |
| Patent Issue Date Used in PTA Calculation Critical
| 07 Dec, 2004 | US6828339 |
| Issue Notification Mailed Critical
| 18 Nov, 2004 | US6828339 |
| Receipt into Pubs | 15 Nov, 2004 | US6828339 |
| Dispatch to FDC | 11 Nov, 2004 | US6828339 |
| Receipt into Pubs | 05 Nov, 2004 | US6828339 |
Amlodipine Besylate's Family Patents
